Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 19;8(4):231.
doi: 10.3390/tropicalmed8040231.

Proceedings of the 5th Asia Dengue Summit

Nattachai Srisawat  1   2   3   4 , Duane J Gubler  5 , Tikki Pangestu  6 , Usa Thisyakorn  1   7 , Zulkifli Ismail  8 , Daniel Goh  9 , Maria Rosario Capeding  10 , Lulu Bravo  11 , Sutee Yoksan  12 , Terapong Tantawichien  13 , Sri Rezeki Hadinegoro  14 , Kamran Rafiq  15 , Valentina Sanchez Picot  16 , Eng Eong Ooi  5
Affiliations

Proceedings of the 5th Asia Dengue Summit

Nattachai Srisawat et al. Trop Med Infect Dis. .

Abstract

The 5th Asia Dengue Summit, themed "Roll Back Dengue", was held in Singapore from 13 to 15 June 2022. The summit was co-convened by Asia Dengue Voice and Action (ADVA), Global Dengue and Aedes transmitted Diseases Consortium (GDAC), Southeast Asian Ministers of Education Tropical Medicine and Public Health Network (SEAMEO TROPMED), and the Fondation Mérieux (FMx). Dengue experts from academia and research and representatives from the Ministries of Health, Regional and Global World Health Organization (WHO), and International Vaccine Institute (IVI) participated in the three-day summit. With more than 270 speakers and delegates from over 14 countries, 12 symposiums, and 3 full days, the 5th ADS highlighted the growing threat of dengue, shared innovations and strategies for successful dengue control, and emphasized the need for multi-sectoral collaboration to control dengue.

Keywords: Asia; dengue; dengue control; innovations; strategies; therapeutic targets; vaccine update.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Strategy to reduce preventable dengue deaths to zero.
See this image and copyright information in PMC

References

    1. Bhatt S., Gething P.W., Brady O.J., Messina J.P., Farlow A.W., Moyes C.L., Drake J.M., Brownstein J.S., Hoen A.G., Sankoh O., et al. The global distribution and burden of dengue. Nature. 2013;496:504–507. doi: 10.1038/nature12060. - DOI - PMC - PubMed
    1. Stanaway J.D., Shepard D.S., Undurraga E.A., Halasa Y.A., Coffeng L.E., Brady O.J., Hay S.I., Bedi N., Bensenor I.M., Castañeda-Orjuela C.A., et al. The global burden of dengue: An analysis from the Global Burden of Disease Study 2013. Lancet Infect. Dis. 2016;16:712–723. doi: 10.1016/S1473-3099(16)00026-8. - DOI - PMC - PubMed
    1. Soe A.M., Ngwe Tun M.M., Nabeshima T., Myat T.W., Htun M.M., Lin H., Hom N.S., Inoue S., Nwe K.M., Aye L.P.P., et al. Emergence of a Novel Dengue Virus 3 (DENV-3) Genotype-I Coincident with Increased DENV-3 Cases in Yangon, Myanmar between 2017 and 2019. Viruses. 2021;13:1152. doi: 10.3390/v13061152. - DOI - PMC - PubMed
    1. Takemura T., Nguyen C.T., Pham H.C., Nguyen T.T., Hoang V.M.P., Nguyen L.K.H., Nabeshima T., Nguyen T.T.T., Le T.Q.M., Moi M.L., et al. The 2017 Dengue virus 1 outbreak in northern Vietnam was caused by a locally circulating virus group. Trop. Med. Health. 2022;50:3. doi: 10.1186/s41182-021-00386-0. - DOI - PMC - PubMed
    1. Luz M.A.V., Nabeshima T., Moi M.L., Dimamay M.T.A., Pangilinan L.S., Dimamay M.P.S., Matias R.R., Mapua C.A., Buerano C.C., de Guzman F., et al. An Epidemic of Dengue Virus Serotype-4 during the 2015–2017: The Emergence of a Novel Genotype IIa of DENV-4 in the Philippines. Jpn. J. Infect. Dis. 2019;72:413–419. doi: 10.7883/yoken.JJID.2019.208. - DOI - PubMed

Publication types

LinkOut - more resources